Recent Updates

Modified on: 
May 13, 2019

Report

Enhancing Living Donation: A Canadian Forum (October 2006) PDF


Background documents:

Organs and Tissues
Modified on: 
May 13, 2019

Report and recommendations

  • End-of-Life Conversations with Families of Potential Donors: Leading Practices in Offering the Opportunity for Donation (August 2014) PDF 

Journal publications

Organs and Tissues
Modified on: 
May 13, 2019

Report and recommendations

  • Canadian Guidelines for Controlled Pediatric Donation after Circulatory Determination of Death (September 2017) PDF

Journal publications

Organs and Tissues
Modified on: 
May 13, 2019

Full Report

  • Brain blood flow in the neurological determination of death (February 2007) PDF

Journal publications

Organs and Tissues
Modified on: 
May 13, 2019

Full report and recommendations 

  • International Guidelines for the Determination of Death – Phase I (May 2012) PDF

Journal publication

Organs and Tissues
Modified on: 
May 13, 2019

This first chapter of the Clinical Guide to Transfusion provides an overview of the blood system in Canada, the regulations and standards that are in place and the organizations and professionals that, together, ensure transfusion medicine safety for Canadian patients. 

Transfusion
Modified on: 
May 13, 2019

Author: Mindy Goldman, MD, FRCPC
Online publication date: March 2012, updated July 2018

Transfusion
Modified on: 
Apr 2, 2019

Modified or specialty blood components may be useful in specific clinical settings to reduce the risk of transfusion-related harm. Specialty blood products available to physicians include CMV-seronegative, irradiated, and washed red blood cells or platelets. This chapter describes the preparation of these blood components and the clinical setting in which they are of greatest benefit.

Transfusion
Modified on: 
Feb 26, 2019

Transfusion-related acute lung injury (TRALI) is a rare but serious syndrome characterized by sudden acute respiratory distress following transfusion. It is defined as new, acute lung injury (ALI) during or within six hours after blood product administration in the absence of temporally-associated risk factors for ALI. All plasma-containing blood products have been implicated in TRALI, including rare reports with IVIg and cryoprecipitate.

Transfusion
Modified on: 
Feb 26, 2019

Blog Landing Page

Organs and Tissues

Pages